Maternal obesity is associated with a sex-specific epigenetic programming in human neonatal monocytes

Epigenomics. 2020 Nov;12(22):1999-2018. doi: 10.2217/epi-2020-0098. Epub 2020 Dec 4.

Abstract

Aim: To determine changes in global DNA methylation in monocytes from neonates of women with obesity, as markers of an immune programming resulting from maternal obesity. Materials & methods: Cord blood monocytes were obtained from neonates born to women with obesity and normal weight, genome-wide differentially methylated CpGs were determined using an Infinium MethylationEPIC-BeadChip (850K). Results: No clustering of samples according to maternal BMI was observed, but sex-specific analysis revealed 71,728 differentially methylated CpGs in female neonates from women with obesity (p < 0.01). DAVID analysis showed increased methylation levels within genes involved in the innate immune response and inflammation. Conclusion: Maternal obesity induces, in a sex-specific manner, an epigenetic programming of monocytes that could contribute to disease later in life. Clinical trial registry: This study is registered in ClinicalTrials.gov NCT02903134.

Keywords: DNA methylation; fetal programming; maternal obesity; monocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cells, Cultured
  • CpG Islands
  • DNA Methylation
  • Epigenesis, Genetic*
  • Female
  • Humans
  • Immunity, Innate / genetics
  • Infant, Newborn
  • Inflammation Mediators / blood
  • Male
  • Monocytes / metabolism*
  • Obesity, Maternal*
  • Pregnancy
  • Sex Characteristics
  • Young Adult

Substances

  • Inflammation Mediators

Associated data

  • ClinicalTrials.gov/NCT02903134